CXCR7 抗体
(Chemokine (C-X-C Motif) Receptor 7 (CXCR7))
This gene encodes a member of the G-protein coupled receptor family. Although this protein was earlier thought to be a receptor for vasoactive intestinal peptide (VIP), it is now considered to be an orphan receptor, in that its endogenous ligand has not been identified. The protein is also a coreceptor for human immunodeficiency viruses (HIV). Translocations involving this gene and HMGA2 on chromosome 12 have been observed in lipomas. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CXCR7 抗体 | 人 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (AA 151-250) | 人 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (AA 311-360) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (AA 50-150) | 人 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant CXCR7 抗体 | 人 | 兔 Monoclonal |
|
|
|
| CXCR7 抗体 (Extracellular Domain) | 人, 小鼠, 大鼠, 犬, 马, Bat, Cow, Hamster, Pig, 兔 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (Cytoplasmic Domain) | 人, 马 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (Internal Region) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant CXCR7 抗体 | 人 | Human, 兔 Chimeric |
|
|
|
| CXCR7 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| CXCR7 抗体 (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| CXCR7 抗体 (C-Term) | 人, 小鼠, 大鼠, 猴 | 兔 Polyclonal |
|
|
|
| CXCR7 抗体 (C-Term) | 人 | 山羊 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- PLA (Proximity Ligation Assay: 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
7 references
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 151-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB23520
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 330-358, C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB24391
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 333-362, C-Term
Primary Antibody
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 311-360
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 50-150
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 23GB595
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠, 犬, 马, Bat, Cow, Hamster, Pig, 兔
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Extracellular Domain
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 马
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Cytoplasmic Domain
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- Human, 兔
- 克隆形成能力
- Chimeric
- 克隆
- DMC443
- 标记
- unconjugated
- Fragment
- Fc fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 10D1-J16
- 标记
- PE
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 10D1-J16
- 标记
- FITC
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Latest Publications for our CXCR7 抗体
: "Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling." in: Cell death & disease, Vol. 11, Issue 5, pp. 307, (2020) (PubMed).
: "Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration." in: Oncogene, Vol. 38, Issue 1, pp. 73-87, (2019) (PubMed).
: "CXCR7 promotes melanoma tumorigenesis via Src kinase signaling." in: Cell death & disease, Vol. 10, Issue 3, pp. 191, (2019) (PubMed).
: "Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer." in: Cancer research, Vol. 79, Issue 10, pp. 2580-2592, (2019) (PubMed).
: "CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells." in: Cell death & disease, Vol. 10, Issue 8, pp. 562, (2019) (PubMed).
: "CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor." in: Cancers, Vol. 11, Issue 4, (2019) (PubMed).
: "Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients." in: Cancer science, Vol. 109, Issue 1, pp. 154-165, (2018) (PubMed).
: "CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis." in: Molecular bioSystems, Vol. 13, Issue 10, pp. 2116-2124, (2018) (PubMed).
: "CXCR7/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells." in: Heliyon, Vol. 4, Issue 3, pp. e00557, (2018) (PubMed).
: "The Role of CXCL12 Axis in Lung Metastasis of Colorectal Cancer." in: Journal of Cancer, Vol. 9, Issue 21, pp. 3898-3903, (2018) (PubMed).
: "Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration." in: Oncogene, Vol. 38, Issue 1, pp. 73-87, (2019) (PubMed).
: "CXCR7 promotes melanoma tumorigenesis via Src kinase signaling." in: Cell death & disease, Vol. 10, Issue 3, pp. 191, (2019) (PubMed).
: "Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer." in: Cancer research, Vol. 79, Issue 10, pp. 2580-2592, (2019) (PubMed).
: "CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells." in: Cell death & disease, Vol. 10, Issue 8, pp. 562, (2019) (PubMed).
: "CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor." in: Cancers, Vol. 11, Issue 4, (2019) (PubMed).
: "Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients." in: Cancer science, Vol. 109, Issue 1, pp. 154-165, (2018) (PubMed).
: "CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis." in: Molecular bioSystems, Vol. 13, Issue 10, pp. 2116-2124, (2018) (PubMed).
: "CXCR7/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells." in: Heliyon, Vol. 4, Issue 3, pp. e00557, (2018) (PubMed).
: "The Role of CXCL12 Axis in Lung Metastasis of Colorectal Cancer." in: Journal of Cancer, Vol. 9, Issue 21, pp. 3898-3903, (2018) (PubMed).
Aliases for CXCR7 抗体
atypical chemokine receptor 3 (ACKR3) 抗体ORF 74; similar to Kaposi's sarcoma-associated herpesvirus ORF 74 (MmrVgp88) 抗体
atypical chemokine receptor 3 (Ackr3) 抗体
atypical chemokine receptor 3 L homeolog (ackr3.L) 抗体
ackr3 抗体
AW541270 抗体
CMKOR1 抗体
Cmkor1 抗体
CXC-R7 抗体
CXCR-7 抗体
CXCR7 抗体
Cxcr7 抗体
cxcr7 抗体
GPR159 抗体
RDC-1 抗体
RDC1 抗体
Rdc1 抗体
rdc1 抗体
xcxcr7 抗体
您还需要查找其他产品吗？
You are here:
